US3340152A
(en)
*
|
1963-12-06 |
1967-09-05 |
Ciba Geigy Corp |
Compressed oral drug tablet granulations containing admixed therein about 1% to 15% of polyfluorocarbon type polymer lubricant powders in about 1 to 150 micron particle size
|
US3361632A
(en)
*
|
1964-05-08 |
1968-01-02 |
Hoechst Ag |
Medicinal preparations having a protracted activity and method of making them
|
CH468192A
(en)
*
|
1964-06-19 |
1969-02-15 |
Ciba Geigy |
Process for the manufacture of medicaments in pearl form
|
US3492397A
(en)
*
|
1967-04-07 |
1970-01-27 |
Warner Lambert Pharmaceutical |
Sustained release dosage in the pellet form and process thereof
|
US3538214A
(en)
*
|
1969-04-22 |
1970-11-03 |
Merck & Co Inc |
Controlled release medicinal tablets
|
AU449029B2
(en)
*
|
1969-08-28 |
1974-04-17 |
Commonwealth Scientific And Industrial Research Organisation |
Device for administration to ruminants
|
US3773919A
(en)
*
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
DE2010416B2
(en)
*
|
1970-03-05 |
1979-03-29 |
Hoechst Ag, 6000 Frankfurt |
Orally applicable dosage form with sustained release effect
|
CS157213B1
(en)
*
|
1971-01-08 |
1974-09-16 |
|
|
US3732865A
(en)
*
|
1971-01-13 |
1973-05-15 |
Alza Corp |
Osmotic dispenser
|
US3906086A
(en)
*
|
1971-07-19 |
1975-09-16 |
Richard G Powers |
Timed-release aspirin
|
US3938515A
(en)
*
|
1971-12-20 |
1976-02-17 |
Alza Corporation |
Novel drug permeable wall
|
US3954959A
(en)
*
|
1973-03-28 |
1976-05-04 |
A/S Alfred Benzon |
Oral drug preparations
|
GB1468172A
(en)
*
|
1973-03-28 |
1977-03-23 |
Benzon As Alfred |
Oral drug preparations
|
DE2336218C3
(en)
*
|
1973-07-17 |
1985-11-14 |
Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz |
Oral dosage form
|
US3952741A
(en)
*
|
1975-01-09 |
1976-04-27 |
Bend Research Inc. |
Controlled release delivery system by an osmotic bursting mechanism
|
US4344857A
(en)
*
|
1975-12-22 |
1982-08-17 |
The United States Of America As Represented By The Secretary Of Agriculture |
Encapsulation by entrapment
|
US4277364A
(en)
*
|
1975-12-22 |
1981-07-07 |
The United States Of America As Represented By The Secretary Of Agriculture |
Encapsulation by entrapment
|
US4016880A
(en)
*
|
1976-03-04 |
1977-04-12 |
Alza Corporation |
Osmotically driven active agent dispenser
|
US4111201A
(en)
*
|
1976-11-22 |
1978-09-05 |
Alza Corporation |
Osmotic system for delivering selected beneficial agents having varying degrees of solubility
|
US4111202A
(en)
*
|
1976-11-22 |
1978-09-05 |
Alza Corporation |
Osmotic system for the controlled and delivery of agent over time
|
US4111203A
(en)
*
|
1976-11-22 |
1978-09-05 |
Alza Corporation |
Osmotic system with means for improving delivery kinetics of system
|
US4207890A
(en)
*
|
1977-01-04 |
1980-06-17 |
Mcneilab, Inc. |
Drug-dispensing device and method
|
FR2377196A1
(en)
*
|
1977-01-13 |
1978-08-11 |
Lipha |
DRUG COMPOSITION FOR ORAL USE
|
GB1561204A
(en)
*
|
1977-06-01 |
1980-02-13 |
Ici Ltd |
Sustained release pharmaceutical composition
|
FR2397840B1
(en)
*
|
1977-07-22 |
1981-03-20 |
Cherqui Jean |
|
FR2407720A1
(en)
*
|
1977-11-08 |
1979-06-01 |
Lipha Lyonnaise Indle Pharmace |
Oral sustained-action capsule formulations - of drug and excipient which swells in contact with digestive juices
|
US4190642A
(en)
*
|
1978-04-17 |
1980-02-26 |
Alza Corporation |
Ocular therapeutic system for dispensing a medication formulation
|
US4153677A
(en)
*
|
1978-05-18 |
1979-05-08 |
Sterling Drug Inc. |
Controlled-release composition
|
DD146547A5
(en)
*
|
1978-07-15 |
1981-02-18 |
Boehringer Sohn Ingelheim |
MEDICINAL RETARDANT SHAPE WITH UNFORGETTABLE POROESEN DIFFUSION SHELLS
|
SE426548B
(en)
*
|
1978-12-05 |
1983-01-31 |
Haessle Ab |
SOLID PHARMACEUTICAL PREPARATION INCLUDING A THERAPEUTICALLY EFFECTIVE HEART GYCLOSIDE AND POLYMER
|
US4173626A
(en)
*
|
1978-12-11 |
1979-11-06 |
Merck & Co., Inc. |
Sustained release indomethacin
|
SE7813246L
(en)
*
|
1978-12-22 |
1980-06-23 |
Haessle Ab |
FIXED PHARMACEUTICAL PREPARATION INCLUDING BODIES WITH MULTIPLE LAYERS
|
US4252786A
(en)
*
|
1979-11-16 |
1981-02-24 |
E. R. Squibb & Sons, Inc. |
Controlled release tablet
|
FR2470599A1
(en)
*
|
1979-12-07 |
1981-06-12 |
Panoz Donald |
IMPROVEMENTS IN PROCESSES FOR THE PREPARATION OF GALENIC SHAPES WITH DELAYED ACTION AND PROGRAMMED RELEASE AND GALENIC FORMS OF MEDICAMENTS THUS OBTAINED
|
DE3000979A1
(en)
*
|
1980-01-12 |
1981-07-23 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
NEW DIPYRIDAMOL RETARD FORMS AND METHOD FOR THEIR PRODUCTION
|
US4327725A
(en)
*
|
1980-11-25 |
1982-05-04 |
Alza Corporation |
Osmotic device with hydrogel driving member
|
DE3126703A1
(en)
|
1981-07-07 |
1983-01-27 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
BROMHEXIN RETARD FORM AND METHOD FOR THEIR PRODUCTION
|
US4587118A
(en)
*
|
1981-07-15 |
1986-05-06 |
Key Pharmaceuticals, Inc. |
Dry sustained release theophylline oral formulation
|
ATE34300T1
(en)
*
|
1981-07-15 |
1988-06-15 |
Key Pharma |
EXTENDED RELEASE THEOPHYLLINE.
|
JPS5867616A
(en)
*
|
1981-10-15 |
1983-04-22 |
Tanabe Seiyaku Co Ltd |
Enteric microcapsule and its preparation
|
US4508702A
(en)
*
|
1982-06-14 |
1985-04-02 |
Key Pharmaceuticals, Inc. |
Sustained release aspirin
|
US4415547A
(en)
*
|
1982-06-14 |
1983-11-15 |
Sterling Drug Inc. |
Sustained-release pharmaceutical tablet and process for preparation thereof
|
WO1984000004A1
(en)
*
|
1982-06-14 |
1984-01-05 |
Key Pharma |
Sustained release aspirin
|
US4557925A
(en)
*
|
1982-07-08 |
1985-12-10 |
Ab Ferrosan |
Membrane-coated sustained-release tablets and method
|
WO1984000295A1
(en)
*
|
1982-07-09 |
1984-02-02 |
Key Pharma |
Sustained release quinidine dosage form
|
US4634587A
(en)
*
|
1982-07-09 |
1987-01-06 |
Key Pharmaceuticals, Inc. |
Sustained release quinidine dosage form
|
IE55745B1
(en)
*
|
1983-04-06 |
1991-01-02 |
Elan Corp Plc |
Sustained absorption pharmaceutical composition
|
US4555399A
(en)
*
|
1983-11-18 |
1985-11-26 |
Key Pharmaceuticals, Inc. |
Aspirin tablet
|
FR2556965B1
(en)
*
|
1983-12-21 |
1986-08-22 |
Rhone Poulenc Sante |
NEW GALENIC FORM OF CONTROLLED RELEASE KETOPROFEN
|
DE3403329A1
(en)
*
|
1984-02-01 |
1985-08-01 |
Horst Dr. 4019 Monheim Zerbe |
PHARMACEUTICAL PRODUCT IN THE FORM OF PELLETS WITH CONTINUOUS, DELAYED DELIVERY OF ACTIVE SUBSTANCES
|
US4629619A
(en)
*
|
1984-09-05 |
1986-12-16 |
Ab Ferrosan |
Membrane-coated sustained-release tablets and method
|
US4629620A
(en)
*
|
1984-09-05 |
1986-12-16 |
Ab Ferrosan |
Membrane-coated sustained-release tablets and method
|
IT1176853B
(en)
*
|
1984-10-02 |
1987-08-18 |
Eurand Spa |
PROCEDURE FOR OBTAINING A CONTROLLED RELEASE FORMULATION OF WATER SOLUBLE COMPONENTS
|
GB8518301D0
(en)
*
|
1985-07-19 |
1985-08-29 |
Fujisawa Pharmaceutical Co |
Hydrodynamically explosive systems
|
ES2022454B3
(en)
*
|
1986-06-17 |
1991-12-01 |
Recordati Ind Chimica E Farm S P A |
THERAPEUTIC SYSTEM FOR THE CONTROLLED RELEASE OF DRUGS.
|
US4752470A
(en)
*
|
1986-11-24 |
1988-06-21 |
Mehta Atul M |
Controlled release indomethacin
|
US4871542A
(en)
*
|
1987-04-30 |
1989-10-03 |
Ferring Service Center, N.V. |
Method and apparatus useful for delivering medicinal compositions into the bladder and urinary tract
|
GB8801863D0
(en)
*
|
1988-01-28 |
1988-02-24 |
Fulmer Yarsley Ltd |
Pharmaceutical formulations with controlled drug release
|
FR2643572A1
(en)
*
|
1988-12-22 |
1990-08-31 |
Rhone Poulenc Chimie |
METHOD FOR ENCAPSULATING PARTICLES BY FILMING USING A THERMOPLASTIC SILICONE COPOLYMER
|
US5051305A
(en)
*
|
1988-12-30 |
1991-09-24 |
Arcade, Inc. |
Stabilized perfume-containing microcapsules and method of preparing the same
|
US5275819A
(en)
*
|
1989-02-06 |
1994-01-04 |
Amer Particle Technologies Inc. |
Drug loaded pollen grains with an outer coating for pulsed delivery
|
US5219572A
(en)
*
|
1989-03-17 |
1993-06-15 |
Pitman-Moore, Inc. |
Controlled release delivery device for macromolecular proteins
|
US5007790A
(en)
*
|
1989-04-11 |
1991-04-16 |
Depomed Systems, Inc. |
Sustained-release oral drug dosage form
|
ES2053339T3
(en)
*
|
1990-09-28 |
1994-07-16 |
Pfizer |
DISPENSER DEVICE CONTAINING A HYDROPHOBIC MEDIA.
|
DE4140192C2
(en)
*
|
1991-12-05 |
1996-02-29 |
Alfatec Pharma Gmbh |
Sol-controlled gelatin-based thermocolloid matrix for peroral sustained release forms
|
US5260068A
(en)
*
|
1992-05-04 |
1993-11-09 |
Anda Sr Pharmaceuticals Inc. |
Multiparticulate pulsatile drug delivery system
|
US5260069A
(en)
*
|
1992-11-27 |
1993-11-09 |
Anda Sr Pharmaceuticals Inc. |
Pulsatile particles drug delivery system
|
US5358502A
(en)
*
|
1993-02-25 |
1994-10-25 |
Pfizer Inc |
PH-triggered osmotic bursting delivery devices
|
EP0711166A1
(en)
*
|
1993-07-22 |
1996-05-15 |
Warner-Lambert Company |
Controlled release tacrine drug delivery systems and methods for preparing same
|
NZ270078A
(en)
*
|
1994-12-06 |
1998-05-27 |
Bernard Charles Sherman |
Diltiazem hydrochloride formulation comprising beads with immediate, intermediate, and delayed release dissolution profiles
|
US5798119A
(en)
*
|
1995-06-13 |
1998-08-25 |
S. C. Johnson & Son, Inc. |
Osmotic-delivery devices having vapor-permeable coatings
|
US6531152B1
(en)
|
1998-09-30 |
2003-03-11 |
Dexcel Pharma Technologies Ltd. |
Immediate release gastrointestinal drug delivery system
|
US6632451B2
(en)
|
1999-06-04 |
2003-10-14 |
Dexcel Pharma Technologies Ltd. |
Delayed total release two pulse gastrointestinal drug delivery system
|
EP1349531A1
(en)
|
2001-01-12 |
2003-10-08 |
Sun Pharmaceuticals Industries Ltd. |
Spaced drug delivery system
|
PT1377276E
(en)
*
|
2001-04-10 |
2011-12-30 |
Sun Pharma Advanced Res Co Ltd |
Timed pulse release composition
|
AU2002356418A1
(en)
*
|
2001-10-08 |
2003-04-22 |
Sun Pharmaceutical Industries Limited |
An antispasmodic agent spaced drug delivery system
|
WO2004108067A2
(en)
*
|
2003-04-03 |
2004-12-16 |
Sun Pharmaceutical Industries Limited |
Programmed drug delivery system
|
US8029822B2
(en)
*
|
2003-05-22 |
2011-10-04 |
Osmotica Kereskedelmi és Seolgáltató KFT |
Rupturing controlled release device having a preformed passageway
|
US20050031688A1
(en)
*
|
2003-08-04 |
2005-02-10 |
Ayala William J. |
Positive wakeup pharmaceutical sleep system with compatible pre-bedtime administration
|
US20050265955A1
(en)
*
|
2004-05-28 |
2005-12-01 |
Mallinckrodt Inc. |
Sustained release preparations
|
US8637080B2
(en)
*
|
2007-06-28 |
2014-01-28 |
Osmotica Kereskedelmi és Szolgáltató, KFT |
Rupturing controlled release device comprising a subcoat
|
WO2011039686A1
(en)
|
2009-09-30 |
2011-04-07 |
Pfizer Inc. |
Latrepirdine oral sustained release dosage forms
|
WO2012151343A1
(en)
|
2011-05-04 |
2012-11-08 |
Balance Therapeutics, Inc. |
Pentylenetetrazole derivatives
|
EP2586429A1
(en)
*
|
2011-10-26 |
2013-05-01 |
Freund Pharmatec Ltd. |
Multi-unit drug delivery device for pulsatile or sustained release
|
WO2013136183A2
(en)
*
|
2012-03-12 |
2013-09-19 |
Innolipid, As |
Oxidixable fatty acid composition delivery form
|
JP6041823B2
(en)
|
2013-03-16 |
2016-12-14 |
ファイザー・インク |
Tofacitinib oral sustained release dosage form
|
US9566240B2
(en)
|
2014-10-15 |
2017-02-14 |
Clabber Girl Corporation |
Compositions for multiphase, staggered, or sustained release of an active substance
|
WO2021014360A1
(en)
|
2019-07-23 |
2021-01-28 |
Pfizer Inc. |
Oral modified release dosage forms
|
US20220378707A1
(en)
|
2019-11-14 |
2022-12-01 |
Pfizer Inc. |
1-(((2s,3s,4s)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl)methoxy)-7-methoxyisoquinoline-6-carboxamide combinations and oral dosage forms
|